re7312077
/portal/eipf/pb/herceptin/trastuzumab
Herceptin.net
skip to the content
Search
Search
Home
About Herceptin
Herceptin in early BC
Herceptin in metastatic BC
HER2 testing
HER2-positive gastric cancer
SiteMap JG
Tell a friend
Home
About Herceptin
HER2-positive disease
Herceptin Molecule
Mechanism of Action
EU approval and labelling information
Safety Information
Cardiac Safety
General use and storage
Herceptin in early BC
Adjuvant Herceptin
HERA trial
NSABP B-31 trial
NCCTG N9831 trial
BCIRG 006 trial
Treatment duration
Dosage and administration
Clinical trials - Neoadjuvant Herceptin
MDACC neoadjuvant trial
NOAH trial
GeparQuattro trial
Herceptin in metastatic BC
First-line therapy
Herceptin plus Taxanes
H0648g trial
M77001 trial
Herceptin plus other chemotherapies
Traviota trial
BCIRG 007 trial
CHAT trial
US Oncology trial
Herceptin plus Aromatase Inhibitors
TAnDEM trial
Treatment duration
Dosage and administration
Clinical trials in second & further lines of therapy
H0649g trial
GBG-26 trial
EGF104900 trial
HER2 testing
Importance of HER2 testing in breast cancer
Methodologies
Testing algorithm
Quality control and quality assurance
HER2 testing in gastric cancer
HER2-positive gastric cancer
HER2 overexpression in gastric cancer
ToGA trial design